Sanofi in Saudi Arabia: from partners to patients Saudi Corporate Social Responsibility Forum Jeddah - April 9, 2013 Session III: CSR: from partners to customers Simone Mechiche Corporate Social Responsibility Director Sanofi Intercontinental

A global healthcare leader, focused on patients’ needs world’s largest pharmaceutical groups 1 €34. 9 in net sales for 2012 billion of the (1) As of 31 December 2012 Employees (1) in countries , 000 More than Saudi CSR Forum – Jeddah - April 9th,

CSR lies at the core of Sanofi’s business activities “Triple Bottom Line” “The primary area where we can and do have an impact is in healthcare. We have the expertise and resources to make a real difference” C. Viehbacher – CEO 3 Creation of Shared Value Saudi CSR Forum – Jeddah - April 9th, 2013

Sanofi in Saudi Arabia presence 40 employees 240 €140 sales in 2012 million years Legal entity created in May 2011 Saudi CSR Forum – Jeddah - April 9th, 2013 A portfolio of healthcare solutions addressing Saudi patient’s needs Diabetes: oral antidiabetics, insulins and blood glucose monitoring system Cardiovascular diseases and thrombosis Oncology & transplantation Rare diseases Vaccines 4 More than

Source: IDF Diabetes Atlas 5 th edition – 2012 update Saudi CSR Forum – Jeddah - April 9th,

Partnering for Access to Healthcare in Diabetes Access to Healthcare Diabetes Studies to assess status of disease Saudi CSR Forum – Jeddah - April 9th, 2013 Disease awareness Screening campaign Training healthcare professionals Access to medicines Educational compliance programs 6

Raising awareness and screening on diabetes Campaigns conducted in collaboration with key institutions and Ministry of Health hospitals to increase awareness of general public, disseminate messages on healthy lifestyle and ensure early diagnosis: ● Screening tests in malls and hospitals ● 2011 and 2012 : 5 campaigns (1000 individuals) ● 2013 plan : massive A1c testing targeting 2000 individuals. Saudi CSR Forum – Jeddah - April 9th,

Training of primary care physicians (PCP) and diabetes educators ● Training of Saudi PCP on diabetes management guidelines ● Workshops managed by endocrinology consultants ● Focus on remote areas to allow equal distribution of education at MOH directorates ● CME accreditation for attendees in alliance with MOH ● 2011/2012: 800 PCP trained - Plan 2013 :1000 PCP ● Training of diabetes educators and nurses to improve interaction with diabetic patients: ● Alliance with major medical institutions (e.g. King Saud University hospitals) ● Support Diabetes Friendship association in Jeddah ● Sanofi teams educate about insulin and use of devices ● 2011/2012 : 160 educators trained (15 sessions) ● Plan 2013 : 200 educators Saudi CSR Forum – Jeddah - April 9th, PCP: Primary Care Physicians MOH: Ministry of Health CME: Continuous Medical Education

Education of patients and their families to help them manage their diabetes ● Patients education programs with diabetes associations: ● Training sessions with the participation of professional diabetes educators (350 patients over 2011/2012) ● Sponsorship of First diabetes Arabic website ' Diabetes Networking and Forums’ (Since 2007) million viewers from all over the Middle-East 4,000 questions answered by healthcare professionals per year An average of 28,000 daily visits in 2012 ● Type 1 patients camps with children activities in alliance with major institutions and specific educational cartoon (TANTOON) ● Collaboration with Charities (ENSAN) to educate and support patients. In 2012 around 50 diabetic widows trained on diabetes management. Saudi CSR Forum – Jeddah - April 9th,

● Innovative Patient Support Program TAMKEEN developed with King Khalid National Guard Hospital Jeddah: ● Patient education to develop self-management attitude ● Improve compliance to treatment through regular contact with professionally trained and certified educator ● Enhance Saudi experience in building patient’s self- management ● 1 year program in 500 type 1 diabetes patients ● STAR Connect Program ● Dedicated call center with thorough patient follow-up ● Web platform for Doctors and Nurse educators ● Pilot with 1000 patients over 6 months Educational compliance programs Saudi CSR Forum – Jeddah - April 9th,

Tomorrow Sanofi local manufacturing Industrial investment in King Abdullah Economic city: “state of the art” 35K square meter site that will produce 7 M units solid form for the first phase Transfer of technology by training Saudi employees. Construction started in November Commercial batches will be available in Exportation to GCC countries Objectives Fully owned legal entity with pharmaceutical status and manufacturing and distribution capacities to: Secure a steady future supply of products Provides jobs to Saudi citizens Stimulates economic development Increase access to medicines through Minimized regulatory time constraints Local production of generics Provide quick and appropriate response to market demands by Being close to our customers Expanding our affordable medication portfolio Investment 11 Saudi CSR Forum – Jeddah - April 9th, 2013

Limitation of use of a scarce resource: water ● Specific system for purified water: the site will use thermo compression. A system that will consume less water than the reverse osmosis which is the current process used in Sanofi plants ● A tank will collect water effluents and other sources of water. If analysis shows that water features corresponds to local limits set by regulations, this water will be used for gardening. Saudi CSR Forum – Jeddah - April 9th,

Creation of jobs for Saudi citizens ● Sanofi has an agreement with the Authorities to employ Saudi citizens. Therefore, action plans are being designed to: Attract and hire Saudi employees from both genders Train future employees through partnership with universities Saudi CSR Forum – Jeddah - April 9th,

THANK YOU